Specialisti medici di India contrassegnati come investigatori in studi clinici che studiano Carcinoma, cellule squamose
Totale 13 risultati
-
Ajai BS Kumar, MSVisto in:
- Karnataka, Bangalore, Healthcare Global Enterprises Ltd
Prove:- NCT02985255 (Sub-investigatore)
-
Amritanshu Ram, PhDVisto in:
- Karnataka, Bangalore, Healthcare Global Enterprises Ltd
Prove:- NCT02985255 (Sub-investigatore)
-
Kailash C Pandey, MDVisto in:
- Uttarakhand, Haldwani, Nainital, Swami Rama Cancer Hospital & Research Institute
Prove:- NCT01947062 (Sub-investigatore)
-
Kumara Swamy, MDVisto in:
- Karnataka, Bangalore, Healthcare Global Enterprises Ltd
Prove:- NCT02985255 (Sub-investigatore)
-
Nikhil -, MSVisto in:
- Delhi, New Delhi, All India Institute of Medical Sciences
Prove:- NCT01151839 (Investigatore principale)
Condizioni: -
Radheshyam Naik, DMVisto in:
- Karnataka, Bangalore, Healthcare Global Enterprises Ltd
Prove:- NCT02985255 (Sub-investigatore)
-
Raghavendra M Rao, PhDVisto in:
- Karnataka, Bangalore, Healthcare Global Enterprises Ltd
Prove:- NCT02985255 (Sub-investigatore)
-
Ravi Nayar, MSVisto in:
- Karnataka, Bangalore, Healthcare Global Enterprises Ltd
Prove:- NCT02985255 (Sub-investigatore)
-
Sataksi Chaterjee, MSVisto in:
- Karnataka, Bangalore, Healthcare Global Enterprises Ltd
Prove:- NCT03039465 (Sub-investigatore)
- NCT02985255 (Sub-investigatore)
-
Shekhar Patil, DMVisto in:
- Karnataka, Bangalore, Healthcare Global Enterprises Ltd
Prove:- NCT02985255 (Sub-investigatore)
-
Sridhar P Susheela, MDVisto in:
- Uttarakhand, Haldwani, Nainital, Swami Rama Cancer Hospital & Research Institute
Prove:- NCT01947062 (Sub-investigatore)
-
Vijay Agarwal, PhdVisto in:
- Karnataka, Bangalore, Healthcare Global Enterprises Ltd
Prove:- NCT02985255 (Sub-investigatore)
-
Vikram Maiya, MDVisto in:
- Karnataka, Bangalore, Healthcare Global Enterprises Ltd
Prove:- NCT02985255 (Sub-investigatore)
Prove cliniche su Carcinoma, cellule squamose
-
Genentech, Inc.ReclutamentoMelanoma | Cancro cervicale | HCC | Tumore gastrico | Cancro esofageo | NSCLC | Carcinoma uroteliale | HNSCC | Tumori solidi localmente avanzati o metastatici | TNBC | Clear Cell RCCCorea, Repubblica di, Olanda, Spagna, Stati Uniti, Australia, Canada, Belgio
-
The Netherlands Cancer InstitutePfizerReclutamentoCarcinoma a cellule renaliOlanda
-
National Cancer Centre, SingaporeTerminatoLINFOMA EXTRANODALE NK-T-CELLSingapore
-
Medical College of WisconsinUniversity of Wisconsin, Madison; AmgenReclutamentoLeucemia linfoblastica acuta a cellule B | Leucemia linfoblastica acuta infantile a cellule B | B-Cell ALL, InfanziaStati Uniti
-
National Cancer Institute (NCI)NCIC Clinical Trials Group; Southwest Oncology Group; Cancer and Leukemia Group BCompletatoCarcinoma a cellule renali a cellule chiare | Cancro a cellule renali in stadio III AJCC v7 | Cancro a cellule renali in stadio II AJCC v7 | Stadio I Renal Cell Cancer AJCC v6 e v7Stati Uniti, Canada, Porto Rico
-
National Cancer Institute (NCI)TerminatoCarcinoma a cellule renali a cellule chiare | Carcinoma a cellule renali metastatico | Cancro a cellule renali in stadio III AJCC v7 | Cancro a cellule renali in stadio IV AJCC v7 | Cancro a cellule renali in stadio II AJCC v7 | Stadio I Renal Cell Cancer AJCC v6 e v7Stati Uniti
-
Peloton Therapeutics, Inc., a subsidiary of Merck...National Institutes of Health (NIH)CompletatoCarcinoma a cellule renali a cellule chiare | Malattia di Von Hippel-Lindau | Clear Cell RCC | ccRCC | Mutazione del gene VHL | Sindrome VHL | Inattivazione del gene VHL | VHL | Von Hippel | Malattia di Von Hippel | Sindrome di von Hippel-Lindau, modificatori diStati Uniti